The findings imply that GLP-1 may have an impact on reproductive hormones, pointing to possible treatment approaches for type 2 diabetes and obesity-related hypogonadism in males (105). This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.